AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Zero Based Budgeting Tips 2023 update highlights practical techniques to optimize spending, set realistic allocations, and grow savings for you and your family.
16,371 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Morgan Stanley labels Microsoft the most under-owned megacap as the stock slides this year. A $50 billion AI investme...
ETH activity climbs to record levels in Q1 2026 even as price declines and fees shrink. Analysts call it a classic re...
Hemp farmers, processors and retailers brace for a sweeping federal ban on most hemp-derived THC products, expected t...
When Intuitive Machines announced a major equity raise, the stock sold off hard. But a disciplined look shows the mov...
Traders are chasing the best stocks trade opportunities in a volatile February session. The focus is on highly liquid...
Travel rewards can feel like extra money in your pocket, but taxes can complicate the picture. This guide explains wh...
For years, Annaly stock drew steady income seekers. Today, a different financial stock could outperform on yield and ...
A SpaceX IPO could ripple across tech and autos. This guide explains how spacex should help rivian through AI compute...
A Michigan-based class-action accuses Veterans United Home Loans of misleading branding tied to VA affiliation, alleg...
As Micron Technology rides AI-driven memory demand, investors debate a bold forecast. Market models suggest a potenti...
Landlords are facing rising insurance premiums. A silicon valley innovation that blends digital twins with real-time ...